13F-HR filed by PFM Health Sciences, LP
PFM Health Sciences, LP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 75 holding rows worth $2,162,633,000.
- Accession
- 0001104659-20-125785
- Filer
- CIK 1442756
- Filed
- 2020-11-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 77 entries on the cover page, a total value of $2,162,633,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,162,633,000 with VALUE read as thousands by filing date, 13F file number 028-13169. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerPartner Investment Management, L.P.028-13168
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| OUTSET MEDICAL INC | 690145107 | COM | 2,872,990 | $130,591,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 1,343,570 | $114,244,000 | thousands by filing date | |
| INVESCO QQQ TR | 46090E103 | COM | 381,500 | $105,996,000 | thousands by filing date | put |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,359,420 | $105,600,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 703,817 | $80,538,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 1,078,089 | $68,124,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 302,999 | $55,376,000 | thousands by filing date | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 337,987 | $53,277,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 700,052 | $53,260,000 | thousands by filing date | |
| PENUMBRA INC COM | 70975L107 | Stock | 239,397 | $46,534,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 364,940 | $45,501,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 318,232 | $44,330,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 501,750 | $43,948,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 2,536,932 | $43,483,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061GAH4 | NOTE 0.599% 8/0 | 40,300,000 | $42,361,000 | thousands by filing date | principal |
| AERIE PHARMACEUTICALS INC | 00771VAB4 | NOTE 1.500%10/0 | 51,850,000 | $41,948,000 | thousands by filing date | principal |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 249,068 | $41,358,000 | thousands by filing date | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 167,008 | $39,766,000 | thousands by filing date | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 487,842 | $38,940,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 163,663 | $35,242,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 926,000 | $33,984,000 | thousands by filing date | call |
| HUMANA INC COM | 444859102 | Stock | 77,740 | $32,176,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 162,524 | $29,748,000 | thousands by filing date | |
| BLOCK INC CL A | 852234103 | Stock | 181,509 | $29,504,000 | thousands by filing date | |
| PPD INC | 69355F102 | COM | 787,863 | $29,143,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 1,270,070 | $28,564,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 340,000 | $28,203,000 | thousands by filing date | call |
| Elevance Health, Inc. | 036752103 | COM | 103,455 | $27,787,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 1,872,012 | $27,743,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 143,323 | $26,983,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,294,977 | $26,236,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 2,227,611 | $26,219,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 157,100 | $26,086,000 | thousands by filing date | call |
| BIOGEN INC COM | 09062X103 | Stock | 89,716 | $25,451,000 | thousands by filing date | |
| SCHEIN HENRY INC | 806407102 | COM | 402,310 | $23,648,000 | thousands by filing date | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 121,323 | $23,184,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 200,000 | $22,286,000 | thousands by filing date | put |
| Gilead Sciences,Inc. | 375558103 | COM | 350,000 | $22,117,000 | thousands by filing date | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 286,200 | $21,774,000 | thousands by filing date | call |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 387,900 | $21,257,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 841,194 | $20,618,000 | thousands by filing date | |
| Microsoft Corp | 594918104 | COM | 95,177 | $20,019,000 | thousands by filing date | |
| REVVITY INC | 714046109 | COM | 147,000 | $18,450,000 | thousands by filing date | |
| HOLOGIC INC | 436440101 | COM | 272,193 | $18,093,000 | thousands by filing date | |
| NXP SEMICONDUCTORS N V COM | N6596X109 | Stock | 144,881 | $18,083,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 478,361 | $17,556,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 421,087 | $17,370,000 | thousands by filing date | |
| Deere & Company | 244199105 | COM | 76,336 | $16,918,000 | thousands by filing date | |
| Amazon.com, Inc | 023135106 | COM | 5,342 | $16,821,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 1,126,325 | $16,005,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 775,794 | $15,764,000 | thousands by filing date | |
| NVIDIA Corp | 67066G104 | COM | 25,911 | $14,024,000 | thousands by filing date | |
| APTIV PLC | G6095L109 | SHS | 150,794 | $13,825,000 | thousands by filing date | |
| NextEra Energy,Inc. | 65339F101 | COM | 47,151 | $13,087,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 2,936,990 | $12,688,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 381,990 | $12,575,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 360,313 | $12,539,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 441,155 | $10,995,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 137,960 | $10,667,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 406,467 | $10,028,000 | thousands by filing date | |
| SHOPIFY INC | 82509L107 | CL A SUB VTG SHS | 9,454 | $9,671,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 628,272 | $8,827,000 | thousands by filing date | |
| Visa Inc | 92826C839 | COM | 43,468 | $8,692,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 120,000 | $8,489,000 | thousands by filing date | put |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 224,266 | $8,457,000 | thousands by filing date | |
| SENSATA TECHNOLOGIES HLDG PL | g8060n102 | SHS | 193,585 | $8,351,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 1,056,343 | $7,849,000 | thousands by filing date | |
| ATHIRA PHARMA INC | 04746L104 | COM | 392,489 | $7,245,000 | thousands by filing date | |
| ZENDESK INC | 98936J101 | COM | 67,034 | $6,899,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 849,440 | $6,779,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 240,000 | $4,114,000 | thousands by filing date | call |
| AMERICAN WELL CORP | 03044L105 | CL A | 130,000 | $3,853,000 | thousands by filing date | |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 2,000,000 | $3,151,000 | thousands by filing date | principal |
| ACORDA THERAPEUTICS INC | 00484MAA4 | NOTE 1.750% 6/1 | 2,000,000 | $1,200,000 | thousands by filing date | principal |
| Allena Pharmaceuticals, Inc. | 018119107 | COM | 284,285 | $421,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-20-125785 | this filing | 2020-11-16 | acceptance time not in the bulk data set |